Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

639
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

29
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
29
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
Cancer Vaccines01:30

Cancer Vaccines

488
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dependent latent class partial credit models for careless and insufficient effort responding in online survey data.

Behavior research methods·2026
Same author

Planned missingness in intensive longitudinal studies: Extensions and comparisons of multiform designs.

Behavior research methods·2026
Same author

Effects of encapsulated algae oil supplements on the production of docosahexaenoic acid-enriched milk in mid-lactation dairy cows.

JDS communications·2026
Same author

Epilepsy-IEDs: An automated machine learning model for detecting interictal epileptiform discharges from scalp electroencephalograms.

iScience·2026
Same author

Bayesian evaluation for latent variable models: A tutorial on computing information criteria and bayes factors with the r package bleval.

Psychological methods·2026
Same author

Association between red blood cell distribution width-to-albumin ratio with erectile dysfunction in US men: Insights from national cross-sectional study in NHANES 2001 to 2004.

Medicine·2026

Related Experiment Video

Updated: Aug 24, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.0K

Vaccine-associated thrombocytopenia.

GuangTing Gan1, Hongyun Liu1, Ziyang Liang1

  • 1Department of Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Thrombosis Research
|October 20, 2022
PubMed
Summary

Vaccine-associated immune thrombocytopenia (ITP) is a rare adverse reaction. Treatments for vaccine-induced ITP are similar to those for primary ITP, including glucocorticoids and IVIg.

Keywords:
Exacerbation of ITPThrombocytopeniaTreatment principlesVaccination

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.7K

Related Experiment Videos

Last Updated: Aug 24, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.0K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Hematology

Background:

  • Vaccination is crucial for preventing infectious diseases, but adverse reactions can occur.
  • Rarely, serious adverse events like immune thrombocytopenia (ITP) are reported post-vaccination.
  • The measles-mumps-rubella (MMR) vaccine is linked to ITP, primarily in children.

Purpose of the Study:

  • To review vaccine-associated immune thrombocytopenia (ITP).
  • To discuss the incidence and characteristics of ITP following MMR and COVID-19 vaccination.
  • To outline current treatment approaches for vaccine-associated ITP.

Main Methods:

  • Literature review of vaccine-associated immune thrombocytopenia (ITP).
  • Analysis of reported cases and incidence rates for MMR and COVID-19 vaccine-associated ITP.
  • Summary of established treatment protocols for ITP.

Main Results:

  • The measles-mumps-rubella (MMR) vaccine has a demonstrated causal link to ITP (0.087-4 per 100,000 doses), mainly in children.
  • COVID-19 vaccines can also induce thrombocytopenia, typically within weeks post-vaccination, predominantly in the elderly.
  • Patients with pre-existing chronic ITP, especially those post-splenectomy or on multiple medications, may experience exacerbation after COVID-19 vaccination.

Conclusions:

  • Vaccine-associated immune thrombocytopenia (ITP) is a rare but recognized adverse event.
  • Treatment strategies for vaccine-induced ITP mirror those for primary ITP, including glucocorticoids and intravenous immunoglobulin (IVIg).
  • Further research may be needed to fully understand and manage vaccine-associated ITP, particularly in vulnerable populations.